glp-1 and gip/glp-1 medications GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Effects, working principles and target
Description
Clin Pharmacol (2022) 14:617
These changes were accompanied by preservation of structural proteins including aggrecan and collagen II, along with reduced caspase-3mediated apoptosis, suggesting a coordinated reduction in glycation-driven cellular stress and tissue degradation
A larger group loses little or no weight
While they do mention that licensed medical providers will do the prescribing, there are no names, credentials, or board certifications listed
In DIO mice, SG increased the LCA levels in portal veins without changing the abundance of Clostridiales to stimulate the GLP-1 production (11)
Modulating Effect of the PI3-Kinase Inhibitor LY294002 on Cisplatin in Human Pancreatic Cancer Cells
